Literature DB >> 6822911

Urinary trimethylselenonium excretion by the rat: effect of level and source of selenium-75.

A T Nahapetian, M Janghorbani, V R Young.   

Abstract

The purpose of this study was to explore in rats the urinary metabolites of selenium (Se), by using [75Se]selenomethionine, [75Se]selenocystine, and [75Se]selenite, and to assess the effects of low and high levels of Se intake on trimethylselenonium ion (TMSe) excretion in urine. Male adult rats were adapted for 6 weeks to a commercial rat laboratory stock diet (0.25 ppm Se). They were then starved for 24 hours and given an oral dose of either low (16 micrograms Se/kg body weight) or high (1500 micrograms Se/kg body weight) Se as the test Se compounds. Appearance of radioactivity in TMSe and non-TMSe Se metabolites in urine was monitored for 48 hours. About 40% of the 75Se dose was excreted in urine. TMSe was the major urinary Se metabolite (57-69% of urinary 75Se and 16-25% of oral 75Se dose) at high, and a minor urinary Se metabolite (10% of urinary 75Se and 3-4% of oral 75Se dose) at low dose levels of Se and for all three Se test compounds. At least 80% of urinary 75Se and 26-42% of the orally administered 75Se were excreted as non-TMSe Se metabolites in urine under the latter condition. It is hypothesized that at a requirement intake of Se either a trace or no TMSe is excreted in urine, and it becomes a major excretory metabolite of Se when the dietary trace mineral intake exceeds a requirement level, probably serving as a means of detoxification.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6822911     DOI: 10.1093/jn/113.2.401

Source DB:  PubMed          Journal:  J Nutr        ISSN: 0022-3166            Impact factor:   4.798


  3 in total

1.  Analysis of selenium metabolites in human urine using ion exchange chromatography.

Authors:  R Hasunuma; T Ogawa; Y Kawanishi
Journal:  Bull Environ Contam Toxicol       Date:  1993-01       Impact factor: 2.151

2.  Toxicity and chemical form of selenium in the liver of mice orally administered selenocystine for 90 days.

Authors:  T Hasegawa; S Taniguchi; M Mihara; K Nakamuro; Y Sayato
Journal:  Arch Toxicol       Date:  1994       Impact factor: 5.153

Review 3.  Selenium Metabolism and Biosynthesis of Selenoproteins in the Human Body.

Authors:  Waldemar B Minich
Journal:  Biochemistry (Mosc)       Date:  2022-01       Impact factor: 2.487

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.